Ethyl dirazepate
![]() | |
| Identifiers | |
|---|---|
| |
| CAS Number |
23980-14-5 |
| PubChem (CID) | 208941 |
| ChemSpider |
181035 |
| UNII |
74FAA305EW |
| ChEMBL |
CHEMBL2106231 |
| Chemical and physical data | |
| Formula | C18H14Cl2N2O3 |
| Molar mass | 377.221 |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Ethyl dirazepate[1] is a drug which is a benzodiazepine derivative which was developed by Sanofi Winthrop. It has anxiolytic and hypnotic and possibly other characteristic benzodiazepine properties.[2][3][4]
See also
References
- ↑ ZA Patent 6804601
- ↑ "ethyl dirazepate". psychotropics.dk. 2003. Retrieved 7 December 2009.
- ↑ "Drugs of the Future". Thomson Reuters. 6 (11). November 1981.
- ↑ "LIST OF INTERNATIONAL NON-PROPRIETARY NAMES (INNS), PROVIDED FOR PHARMACEUTICAL SUBSTANCES BY THE WORLD HEALTH ORGANIZATION, WHICH ARE FREE OF DUTY" (PDF). Official Journal of the European Communities. eur-lex.europa.eu. 23 October 2001. Retrieved 7 December 2009.
This article is issued from Wikipedia - version of the 9/1/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
